chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2022 at 2:55 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Jan-2022 at 2:55 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Jan-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported by the reporter. Treatment details was not reported by the reporter. Vaccine administration time 14:55:58   This case was linked to MOD-2022-542869 (Patient Link).
Diarrhea; This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced diarrhea. On an unknown date, the outcome of the diarrhea was unknown.   It was unknown if the reporter considered the diarrhea to be related to Shingrix.  Additional details were provided as follows: Th reporter was patient's mother. The age at vaccination was not reported. The patient received Shingrix and experienced diarrhea. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021005930:Same reporter US-GLAXOSMITHKLINE-US2021005938:Same reporter
2/23/15 FEVER, JOINT ACHES AND FATIGUE TREATED WITH TYLENOL. 2/24/15 RASH ON LEGS AND FOREARMS. TREATED WITH BENADRYL.  2/27/15 SYMPTOMS RESOLVED.
As per patient and ER note, she complained of palpitations, hyperventilation, left arm and leg weakness.
Patient received 1st dose of Moderna but based on patients age should have been Pfizer. The father of the patient requested Moderna
Sore throat starting the next day possibly connected to the high pollen count rash no itching just warm and red skin
Pt is a 33 year old female who noted shortly after her anthrax (AVA) #2 on 04 Jan 99 that she developed an itchy rash on both her legs from her knees down to her ankles. She described this as itch, raised bumps (a little bigger than size of pencil head) in clusters that would drain fluid when she would scratch them. She said it looked something like "cold sores". She denied any cultures. She reports that she still has the rash on the lower part of her legs but it is not as bad as before. The rash never completely goes way and has not had a dermatological evaluation. Her MD told her it was dermatitis and to use Eucerin cream. She reports no worsening with subsequent shots and that the rash never extended past her legs. She received her AVA #3 on 20 Jan 99. She reported that her arm was red and swollen to her elbow and that it lasted approx. 2 weeks. She reported recurrent hip problems since an injury she sustained during basic training in 1996. Between Mar-Apr of 99, she began to notice pain in both her knees. This knee pain is persistent today. AVA #4 on 29 Jun 99 - She had arm swelling as before and reported no increase in her rash or knee pain. She did note that this time she had tenderness described as an intense workout feeling in her upper legs. She also noted around this time that she was getting ready to deploy and was exerting herself more than usual. She noticed at this time that her PT scores had decreased and she had decrease stamina. She stated that it felt like her whole body was tired. Later during the fall of 99, she noticed pain in her lower back and had problems with prolonged standing. She also began to experience bilateral hip pain. After a medical evaluation, she received a diagnosis of Iliac Crest Syndrome. Around this time, she was diagnosed with irritable bowel syndrome and gastroesophageal reflux disease. With her AVA #5 on 6 Jul 00 she again noticed arm swelling. She reports that her stamina continued to decrease and her tiredness continued to increase. It was around this time that she started receiving steroid injections for management of back and hip problems. It was between AVA #5 and 6 that she began to suspect that the anthrax might be making her sick. She went to her provider who told her that her symptoms were not the result of the shots. In June 2000, she had a chemical exposure of Lithium Sulfur Dioxide that resulted in chronic asthma. AVA #6 in July 00 while still recovering from the previous exposure and was hospitalized due to the breathing problems. She reported no worsening with the anthrax. While hospitalized she had decreased activity which resulted in increase back, hip, and knee pain. She reported increase fatigue to the point where her arms would get tired and heavy while blow-drying her hair. She also reported that her whole skin became sensitive touch. During 2002, she received a diagnosis of fibromyalgia. AVA #7 In Jul 04 in which she reports no new symptoms but has noticed problems expressing herself and getting her thoughts out. She also reports increase tiredness, pain, and exacerbation of symptoms after any type of exertions.
I had bad brain fog and was mildly delirious for 3 days after vaccination.
Around 9:30 pm on 9/21/2021 (36 hours after receiving the vaccine), my top lip started to swell. The swelling then moved to my left eye and eventually the entire left-side of my face was swollen. We headed to the ER and once we got there, I started to get hives all over the left-side of my body. A few hives appeared on the right-side of my neck and down my right arm. The ER doctor gave me IV Benadryl, Pepcid and a steroid. It is now 10 am on 9/22/2021 and my lips, left-side of face and left eye are still swollen.
This case was reported by a pharmacist via sales rep and described the occurrence of injection site burning in an unspecified number of adult patients who received SHINGRIX (batch number LT533, expiry date 11th October 2020). On an unknown date, the patients received SHINGRIX. On an unknown date, immediately after receiving SHINGRIX, the patients experienced injection site burning. On an unknown date, the outcome of the injection site burning was unknown. It was unknown if the reporter considered the injection site burning to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The reporter had given over 60 SHINGRIX vaccinations over the past month and over the last week and had noticed that, patients complained of it burning. The reporter was not sure if it was specific to the lot number and expiry date which was a box of 10 vaccines. The patients had been cringing when the vaccine was injected as they said it burns very much. The reporter wanted to know if this was normal and had not had this reaction for the first month and over the past week, but had been getting complaints. The reporter wanted to know if this was heard before and if this was to the specific lot number. The reporter agreed to be followed up.
Erythema, swelling, tenderness of the injection site and then entire arm from shoulder down to the fingers. Swelling to size of double the arm size in diameter.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 46 year old white male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2. s (Janssen, Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, 1 total, administered on 25-MAR-2021 into right arm for prophylactic vaccination. It was unknown whether patient had any adverse event following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1) The patient received covid-19 vaccine ad26.cov2.s (Janssen, Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191, expiry: UNKNOWN) dose was not reported, 1 total, administered on 10-DEC-2021 into right arm for prophylactic vaccination. No concomitant medications were reported.  On 20-JAN-2022, the patient tested positive for COVID-19 with rapid at home kit test, earlier he tested negative with a home kit test and later in the day around 15:00 he tested again and tested positive. Hence coded suspected clinical vaccination failure, and suspected covid-19 infection. The patient had slight cough and a headache (Subsumed under suspected covid-19 infection) that had been resolved on same day (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint.; Sender's Comments: V0:20220139590-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
PATIENT REPORTED REDNESS, TENDERNESS, SORENESS IN HER ARM STARTING DAY OF FLU SHOT AND STILL TWO WEEKS AFTER.  SHE COMPLAINED OF TROUBLE SLEEPING FROM SORENESS AND SORENESS WHEN MOVING IT.
Pt received SHINGRIX 12/11/18 at 10:37 am called office 12/14/18 at 1:12 pm reporting adverse rxn. (L) arm swelling at injection site 12/13/18 pm, developed a rash of her torso, resolved with 2 BENADRYL, she mainly called to make me aware as rash had resolved and (L) arm injection site swelling was improving.
This spontaneous report has been received from a registered nurse concerning a 16 year old patient of unknown gender. The patient's medical history, drug allergies, concurrent conditions and concomitant therapies were not reported. On 02-MAY-2017, the patient who was indicated to receive a pediatric dose of VAQTA, received, in error, an adult dose of VAQTA with lot number N002921 and expiration date on 08-APR-2018 (dose and dose number were not provided), administered intramuscularly in the right arm for prophylaxis. The reporter also stated that the ordering healthcare provider thought that the dose should be based on the patient's weight, rather than age. The patient was observed for approximately 15 to 30 minutes after the incorrect dose was administered, and the patient tolerated the dose. No adverse effect was reported. Additional information has been requested.
Rash and itching. Noted generalized red color. States awoke at 0200 with nausea and vomiting.  States she feels chilled but skin feels hot.  Extreme heat reported to be felt on ears and had nasal headache.  Patient states has hx of Lupus.  Referred to primary medical doctor who referred her to an allergy specialist.
FELT BAD Narrative: PT HAS ALZHEIMERS.WIFE SAID HE FELT BAD FOR 24HR BUT WOULD NOT SPECIFY SYMPTOMS
Received Expired 2nd Booster; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired 2nd Booster) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065K21A, 030B21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired 2nd Booster). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired 2nd Booster) outcome was unknown. Concomitant product use was not provided by the reporter.  Patient received an expired second booster of Moderna COVID-19 vaccine on 06-May-2022. No treatment information was provided.
Patient ordered Pentacel and received Vaxelis.  No adverse reaction noted, just extra dose of hep b.
Notice trobbing along the back of my ear, and noticed there were two knots had formed and causing some discomfort.
This spontaneous report was received from a licensed practical nurse refers to a 4 month old patient of unknown gender. The patient was vaccinated with a dose of ROTATEQ, oral, lot number was 1556Z expiration date 12-SEP-2012) on 17-SEP-2012. Concomitant medications were not reported. The expired dose of ROTATEQ was to be the second dose of ROTATEQ. The patient received the first dose of ROTATEQ on 11-JUL-2012 at 2 months of age. No adverse event was reported. Additional information has been requested.
Chills, slight fevor, itching, could not get out of bed for 30 hours, weakness.
I woke up at 3:30 AM and excruciating pain with paralysis in my left hip. It lasted two days..
Severe joint pain to the point of not being able to walk, nausea, headache, rash, fever
BRUISING IN VARIOUS PARTS OF THE BODY; This spontaneous report received from a consumer concerned a 60 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcohol user (very unusual maybe a glass of wine), and non smoker. The patient had no known allergy. The patient previously received covid-19 vaccine ad26. cov2.s (Janssen, Dose number in series 1)(suspension for injection, route of admin not reported, batch number:1805029, expiry: UNKNOWN) dose was not reported, 1 total, administered on 16-MAR-2021 for prophylactic vaccination. The patient had no issues with series 1. The patient received covid-19 vaccine ad26.cov2.s (Janssen, Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 211D21A, expiry: UNKNOWN) dose was not reported, 1 total, administered on 20-NOV-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-DEC-2021 (Post 4 weeks of vaccination), the patient experienced bruising in various parts of the body. The reporter saw 2 on right arm and patient stated she had bruising in various part of body covered by clothing. The reporter stated that bruising appeared after booster dose. The reporter stated that bruising was noticed after doing exercise. (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bruising in various parts of the body. This report was non-serious.
Dizziness; Flu like symptoms; Body ache; Weakness; Chills; Fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 17Jul2021(at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 26Jun2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Jul2021 the patient experienced dizziness, weakness, chills, fever, flu like symptoms, body ache, fatigue and headache, which took a few days to recover. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event dizziness, weakness, chills, fever, flu like symptoms, body ache, fatigue and headache were resolved on an unknown date in 2021.
Patient had numbness in hands and feet.  Went to hospital, was diagnosed with Guillain Barre Syndrome.  Hospitalized for 3 weeks (21 days) then was admitted to inpatient rehab facility for 2 weeks.  Continues with outpatient rehab therapy.  Continues with numbness and difficulty walking.  9/18/07 Reviewed hospital medical records which reveal patient experienced decreased strength of legs x 4 days, trouble w/stairs, tingling of fingers & toes, taste changes, low back pain.  Exam revealed very unsteady gait & dramatically reduced DTRs of LEs which became absent on 2nd hospital day & UEs DTR were then reduced.  Admitted 7/27-8/6/2007.  Neuro consult done.  Patient refused EMG.  Tx w/IVIG x 5 days w/improvement.  D/C to inpatient rehab. FINAL DX: Guillain-Barre syndrome (recurrent).
HIGH BLOOD SUGAR; This spontaneous report received from a patient concerned a 65 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and batch number: 205A21A expiry: 23-JUN-2021) dose was not reported, administered on 20-MAY-2021 for prophylactic vaccination. Concomitant medications included metformin for diabetes. On 28-MAY-2021, the subject experienced high blood sugar. Laboratory data included: Blood sugar abnormal (NR: not provided) 268 mg/dL. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high blood sugar. This report was non-serious.
I believe I may have had symptoms before 03/18/2023, but I was on a skiing trip and attributed it to that. It wasn't until 03/18/2023, that I realized that I was ill and lost my sense of taste. I developed chills, fatigue, a headache that would come and go, nasal congestion, and a cough. I tested myself for COVID-19 on the morning of 03/19/2023 and it was positive. Later that evening, I tested again, and it was still positive. I called and made an appointment and 03/20/2023 was the earliest I could get in to see the doctor. I showed the practitioner my test results and she prescribed PAXLOVID and some MUCINEX. After taking the medication, I got better every day. I tested myself for COVID-19 on 03/24/2023 and it was negative. I tested again the next day and was still negative. My sense of taste has returned, but not to 100%.
fever; Feeling Unwell; This is a spontaneous report received from a Pfizer sponsored program. A contactable consumer (patient's wife) reported a male patient of an unspecified age received first and second dose of BNT162B2 (Covid shot, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: unknown, Expiry Date: unknown), via an unspecified route of administration on 01Mar2021 and 22Mar2021 respectively at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever and feeling unwell. The reporter stated her husband got both of the doses for COVID 19 vaccine and he was experiencing an adverse event like fever and feeling unwell. His first dose was taken last 01Mar2021 and the second dose took last 22Mar2021. She also mentioned that if her husband can take Tylenol. The outcome of event was unknown.  Follow-up activities have been completed and Information related to lot/batch no. has been requested.
sore arm; TThis is a spontaneous report from a contactable consumer (Patient herself) via Pfizer sponsored program. A 67-year-old female received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number ER8732), dose 2 via an unspecified route of administration on 25Mar2021 on left arm as SINGLE DOSE for covid-19 immunization. The patient's medical history includes COPD from 2009 and ongoing, H1N1 from 2009, Diabetes ongoing from an unknown date. The patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number GN6199), dose 1 via an unspecified route of administration on 04Mar2021 on Left Arm as SINGLE DOSE for covid-19 immunisation and experienced sore arm, Thinks first shot was given too high and that's why it hurt more. Concomitant medication are none. Patient experienced sore arm. Patient was not in emergency room. Patient was not in physicians office. There were no Prior Vaccinations (within 4 weeks) vaccine. No relevant test performed. The outcome of event was recovered.
I went unconscious in the middle of the night, I found my self on the bathroom floor and had vomited all over myself and on my bed. My next conscious awareness was 4 in the afternoon when my friend came over and cleaned me up and I was in bed for nearly a week, on the 3rd day I  had really bad back pain.  I don't have back issues or arthritis, I went to urgent care and I was x-rayed and was given pain medicine but it didn't do anything. I went to a hospital about the middle of June, and admitted myself from the ER, then transferred to a nursing home, now I am home going through a pain management facility.  Prior to this vaccine I was a good health.  I am in pain all the time now since May when I got this vaccine.